Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2025 May 23:15:1543608.
doi: 10.3389/fonc.2025.1543608. eCollection 2025.

Commentary: Immune-related intestinal pseudo-obstruction caused by immune checkpoint inhibitors: case report

Jie-Qiang Xia  1 , Jian Fan  1 , Guang-Qing Shi #  2 , Hao Sun #  1
Affiliations
Comment

Commentary: Immune-related intestinal pseudo-obstruction caused by immune checkpoint inhibitors: case report

Jie-Qiang Xia et al. Front Oncol. .
No abstract available

Keywords: PNS-Care Score; PNSs; gastrointestinal pseudo-obstruction; immune checkpoint inhibitor; paraneoplastic neurologic syndromes.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

References

    1. Graus F, Vogrig A, Muniz-Castrillo S, Antoine JG, Desestret V, Dubey D, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm. (2021) 8:e1014. doi: 10.1212/NXI.0000000000001014 - DOI - PMC - PubMed
    1. Duong SL, Pruss H. Paraneoplastic autoimmune neurological syndromes and the role of immune checkpoint inhibitors. Neurotherapeutics. (2022) 19:848–63. doi: 10.1007/s13311-022-01184-0 - DOI - PMC - PubMed
    1. Graus F, Dalmau J. Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors. Nat Rev Clin Oncol. (2019) 16:535–48. doi: 10.1038/s41571-019-0194-4 - DOI - PubMed
    1. Farina A, Villagran-Garcia M, Vogrig A, Zekeridou A, Muniz-Castrillo S, Velasco R, et al. Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes. Lancet Neurol. (2024) 23:81–94. doi: 10.1016/S1474-4422(23)00369-1 - DOI - PubMed
    1. Shi GQ, Lian HN, Wang H, Xia JQ, Ma LJ, Zhou J. Case report: immune checkpoint inhibitor-induced paraneoplastic neurological syndrome in two patients: A case series. Front Oncol. (2024) 14:1404829. doi: 10.3389/fonc.2024.1404829 - DOI - PMC - PubMed

LinkOut - more resources